We are live on
!
Find out more
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
31 hedge funds and large institutions have $2.99M invested in ImmunoCellular Therapeutics, Ltd. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
16% less capital invested
Capital invested by funds: $3.56M → $2.99M (-$571K)
21% less funds holding
Funds holding: 39 → 31 (-8)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
31
Holders Change
-8
Holders Change %
-20.51%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
5
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$226K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$78.3K |
| 3 |
Renaissance Technologies
New York
|
+$75.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$26.2K |
